Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters-Reference-Cited by-同舟云学术

Mineralocorticoid receptor antagonists lead to increased adenosine bioavailability and modulate contractile cardiac parameters

Published:2019-12-09 Issue:5 Volume:35 Page:719-730
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Hermidorff Milla Marques,de Assis Leonardo Vinícius Monteiro^ORCID,Rodrigues Joel Alves,Soares Leôncio Lopes,Andrade Milton Hércules Guerra,Natali Antônio José,Isoldi Mauro Cesar

Funder

FAPEMIG

CNPq

FAPESP

CAPES

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-019-01542-7.pdf

Reference70 articles.

1. Gravez B, Tarjus A, Jaisser F (2013) Mineralocorticoid receptor and cardiac arrhythmia. Clin Exp Pharmacol Physiol 40(12):910–915

2. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure E, Survival Study I (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309–1321

3. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–717

4. Chai W, Danser AH (2006) Why are mineralocorticoid receptor antagonists cardioprotective? Naunyn Schmiedebergs Arch Pharmacol 374(3):153–162

5. Hermidorff MM, de Assis LV, Isoldi MC (2017) Genomic and rapid effects of aldosterone: what we know and do not know thus far. Heart Fail Rev 22(1):65–89

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways;Current Vascular Pharmacology;2021-09